Key facts
- This page summarizes Patrick Spine's Form 4 filing for ACCURAY INC (ARAY).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 04 Dec 2023, 20:50.
Patrick Spine - 30 Nov 2023 Form 4 Insider Report for ACCURAY INC (ARAY)
- Reporting relationship
- SVP, Chief Admin Officer
- Issuer ticker
- ARAY
- Reported as of
- 30 Nov 2023
- Net transaction value
- -$36,653
- SEC form
- 4
- Accepted by SEC
- 04 Dec 2023, 20:50:50 UTC
- Prior SEC filing
- 04 Oct 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/Gina Corradetti, Power of Attorney for Patrick Spine
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Patrick Spine filed Form 4 for ACCURAY INC (ARAY) on 04 Dec 2023.
Change
- Previous filing in this sequence was filed on 04 Oct 2023.
- Current net transaction value: -$36,653.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ARAY
transaction
Common Stock
Sale
- Transaction value
- $36,653
- Shares
- -14,832
- Change %
- -6.3%
- Price
- $2.47
- Shares after
- 219,484
- Date
- 01 Dec 2023
- Ownership
- Direct
- Footnotes
- F1, F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Shares were automatically sold in accordance with Accuray policy for all restricted stock unit (RSU) releases in order to cover tax obligations upon RSU release and is consistent with Accuray practices for all RSU releases of employees located in the United States.
Footnote F2
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.4707 to $2.4871, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Footnote F3
Adjusted to remove shares related to Performance Stock Unit grants erroneously reported on Table I on October 4, 2021 and December 7, 2022.